Skip to content
Home/Companies/Healthcare/ABOLERIS PHARMA
AP

ABOLERIS PHARMA

Healthcare·Belgium·Exited 2024·Held 4yr

ABOLERIS PHARMA is a santé / bien-être company, headquartered in Belgium.

Entry
2020
Hold
4yr
Exit
2024
Est. EV
–

Who owns ABOLERIS PHARMA?

ABOLERIS PHARMA was owned by Turenne Groupe through Capital Santé 2 (2020 vintage) from 2020 to 2024, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Turenne Groupe
Investor
Turenne Groupe
Capital Santé 2 · 2020 · Growth

Key facts

HQBelgium
SectorSanté / Bien-être
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2024

More from Capital Santé 2

Other portfolio companies in the same fund.

Le Petit Souk
Active
E-commerceFrance· 2026
M&C3i
Active
SoftwareFrance· 2026
Agrotech
Active
ConstructionFrance· 2025
ANOTHERCORP.
Active
ConsumerFrance· 2025
Groupe Colibri – Promesse de Fleurs
Active
ConsumerFrance· 2025
Kimialys
Active
IndustrialsFrance· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings